Effectiveness and safety of B cell-targeting biologics in the treatment of lupus nephritis: a systematic review and network meta‑analysis
Objectives To evaluate the effectiveness and safety of different B cell-targeting biological agents combining with standard of care in patients with lupus nephritis (LN).Methods Comprehensive literature searches were conducted using PubMed, Embase, Web of Science, and Central in the Cochran Library,...
Saved in:
| Main Authors: | Xi Zhao, Si-Qi Yang, Man Li, Yao-Guang Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2416605 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis
by: Mariele Gatto, et al.
Published: (2024-04-01) -
Efficacy and safety of biologics, multitarget therapy, and standard therapy for lupus nephritis: a systematic review and network meta-analysis
by: Gui-Qing Tian, et al.
Published: (2024-12-01) -
B cells and treatment progression in lupus nephritis
by: ZHANG Yue-qi, et al.
Published: (2019-01-01) -
End of induction treatment outcomes with a novel cyclophosphamide-based regimen for severe lupus nephritis: Single-center experience from South India
by: V Jayaprakash, et al.
Published: (2020-01-01) -
Efficacy and safety of belimumab therapy in lupus nephritis: a systematic review and meta-analysis
by: Han Zhang, et al.
Published: (2023-12-01)